The burden of hospitalisations for COVID-19 in France: a study of all cases in the national insurance claims database in 2020 by Claire Leboucher, Cécile Blein, Valérie Machuron, Kelly Benyounes, Katell Le lay, Aurélie Millier, Romain Supiot, François Raffi

Get full text

Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease by Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay, Marine Sivignon, Claire Leboucher, Cécile Blein, François Raffi

Get full text

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy. by Josep M Llibre, François Raffi, Graeme Moyle, Georg Behrens, Stephane Bouee, Geraldine Reilly, Peter Borg, David Piontkowsky, Felipe Rogatto

Get full text

Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective by Paul Loubet, Ilies Benotmane, Slim Fourati, Florent Malard, Fanny Vuotto, Elodie Blanchard, François Raffi, Stéphanie Nguyen, Nicolas de Prost, Jérôme Avouac

Get full text

CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. by Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Jim Young, Mina Psichogiou, Laurence Meyer, Sylvie Ayayi, Sophie Grabar, Francois Raffi, Peter Reiss, Brian Gazzard, Mike Sharland, Félix Gutierrez, Niels Obel, Ole Kirk, José M Miro, Hansjakob Furrer, Antonella Castagna, Stéphane De Wit, Josefa Muñoz, Jesper Kjaer, Jesper Grarup, Geneviève Chêne, Heiner Bucher

Get full text